Suchergebnisse - "Fahrner, Jean-Eudes"

PubPharm (19)

1

The polarity and specificity of SARS-CoV2-specific T lymphocyte responses determine disease susceptibility

enthalten in: bioRxiv.org | 2024

von Fahrner, J. | Carrier, A. | De Sousa, E. | +52

2

THE POLARITY AND SPECIFICITY OF SARS-COV2 -SPECIFIC T LYMPHOCYTE RESPONSES AS A BIOMARKER OF DISEASE SUSCEPTIBILITY

enthalten in: Europäisches Patentamt | 2024

von ZITVOGEL LAURENCE | FAHRNER JEAN-EUDES | MAEURER MARKUS | +2

3

Correction : Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers

enthalten in: Cell death & disease | 2024

von Danlos, F. | Grajeda-Iglesias, C. | Durand, S. | +37

ErratumFor: Cell Death Dis. 2021 Mar 11;12(3):258. - PMID 33707411

4

THE POLARITY AND SPECIFICITY OF SARS-COV2 -SPECIFIC T LYMPHOCYTE RESPONSES AS A BIOMARKER OF DISEASE SUSCEPTIBILITY

enthalten in: Europäisches Patentamt | 2023

von ZITVOGEL LAURENCE | FAHRNER JEAN-EUDES | MAEURER MARKUS | +2

5

THE POLARITY AND SPECIFICITY OF SARS-COV2 -SPECIFIC T LYMPHOCYTE RESPONSES AS A BIOMARKER OF DISEASE SUSCEPTIBILITY

enthalten in: Europäisches Patentamt | 2023

von ZITVOGEL LAURENCE | FAHRNER JEAN-EUDES | MAEURER MARKUS | +2

6

A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers

enthalten in: Science (New York, N.Y.) | 2023

von Fidelle, M. | Rauber, C. | Alves Costa Silva, C. | +63

CommentIn: Trends Immunol. 2023 Aug;44(8):568-570. - PMID 37451906

7

Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti-PD-1 + Antiangiogenesis in Malignant Pleural Mesothelioma

enthalten in: Cancer discovery | 2023

von Danlos, F. | Texier, M. | Job, B. | +40

8

THE POLARITY AND SPECIFICITY OF SARS-COV2 -SPECIFIC T LYMPHOCYTE RESPONSES AS A BIOMARKER OF DISEASE SUSCEPTIBILITY

enthalten in: Europäisches Patentamt | 2022

von ZITVOGEL LAURENCE | FAHRNER JEAN-EUDES | MAEURER MARKUS | +2

9

THE POLARITY AND SPECIFICITY OF SARS-COV2 -SPECIFIC T LYMPHOCYTE RESPONSES AS A BIOMARKER OF DISEASE SUSCEPTIBILITY

enthalten in: Europäisches Patentamt | 2022

von ZITVOGEL LAURENCE | FAHRNER JEAN-EUDES | MAEURER MARKUS | +2

10

Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis

enthalten in: bioRxiv.org | 2022

von Goubet, A. | Dubuisson, A. | Geraud, A. | +66